Search results
A New Treatment Offers Hope to Mothers Battling Postpartum Depression
Denton Record-Chronicle· 3 days agoToday, the term for mothers having anxiety and depression after having a baby is called “postpartum...
English Standings
San Francisco Chronicle· 27 minutes agoEnglish Premier League
Healthier Together: Postpartum depression can put new moms, babies at risk
KIRO 7 Seattle-Tacoma· 4 hours agoMay 1 was World Maternal Mental Health Day and it gave doctors and some patients a chance to shine a...
Ex-PPD officer Ryan Pownall, who shot and killed David Jones, to be reinstated after winning...
WHYY· 6 days agoPownall was charged with shooting Jones, who was pulled over while riding a dirt bike. A judge threw...
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN...
The Herald Journal· 1 day agoLipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that dosing of subjects has been completed in the pivotal pharmacokinetic (PK) study designed to support a New Drug ...
Police report
Petersburg Pilot· 15 hours agoApril 24 – The 3rd Street pump station alarm activated. Water Wastewater (W/WW) was notified and responded. An officer spoke to an individual on 2nd Street concerning a civil issue. Found property ...
I thought I could beat postpartum depression on my own, but it was beating me
Motherly via Yahoo News· 5 days agoShe very gently told me she thought I should see the doctor before the six-week appointment, and it...
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoSage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript April 25, 2024 Sage...
Biden replaces Obama-era infrastructure protections to defend against Chinese cyberthreats
CNBC· 2 days agoPresident Joe Biden on Tuesday updated a more than decade-old policy to protect U.S. critical...
Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo...
Benzinga· 11 hours agoReunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to pushing the boundaries of neuroscience, today announced the close of a $103 million Series A financing co-led ...
